Atif J Khan (@theradsofkhan) 's Twitter Profile
Atif J Khan

@theradsofkhan

ID: 1011183162456723456

calendar_today25-06-2018 09:43:47

178 Tweet

413 Followers

156 Following

Samuel Bakhoum (@samuel_bakhoum) 's Twitter Profile Photo

1/ Our joint paper with the @LaughneyLabidentifying how #Chromosomal_Instability and #STING signaling cooperate with the immune system to drive #cancer #metastasis is out in @nature nature.com/articles/s4158…

Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

Congrats to Memorial Sloan Kettering Cancer Center’s Dr. @Michel_Sadelain, Director of the Center for Cell Engineering and the Gene Transfer and Gene Expression Laboratory, who has won the 2024 Breakthrough in Life Sciences for the development of #CART cell immunotherapy.

Congrats to <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>’s Dr. @Michel_Sadelain, Director of the Center for Cell Engineering and the Gene Transfer and Gene Expression Laboratory, who has won the 2024 <a href="/brkthroughprize/">Breakthrough</a> in Life Sciences for the development of #CART cell immunotherapy.
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

Ever wonder if high Oncotype RS retains significance for local regional outcomes in very small breast cancers (T1a/T1b)? Med student Felly Koleoso presented our results beautifully on this question at Astro.

Ever wonder if high Oncotype RS retains significance for local regional outcomes in very small breast cancers (T1a/T1b)?  Med student Felly Koleoso presented our results beautifully on this question at <a href="/astro/">Astro</a>.
Erin Gillespie, MD MPH (@eringillespiemd) 's Twitter Profile Photo

🤔 Should we use DCISion RT to help further stratify low-risk patients w/ grade 1-2 DCIS (per RTOG 9804)? #bcsm #radonc More data presented by Dr. Frank Vicini at #ASTRO2023. Prospective confirmatory RCT ⚖️ under review for funding.

🤔 Should we use DCISion RT to help further stratify low-risk patients w/ grade 1-2 DCIS (per RTOG 9804)? #bcsm #radonc

More data presented by Dr. Frank Vicini at #ASTRO2023. Prospective confirmatory RCT ⚖️ under review for funding.
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

Interesting panel discussion on how to harmonize clinical trial regulatory and research elements to accelerate discovery by scaling trial activity across multiple sites. Led by Luis Diaz and featuring Larry Norton, David Fredrickson (AZ) and others at Cure4Cancer Asia Society NY

Interesting panel discussion on how to harmonize clinical trial regulatory and research elements to accelerate discovery by scaling trial activity across multiple sites. Led by Luis Diaz and featuring Larry Norton, David Fredrickson (AZ) and others at Cure4Cancer <a href="/AsiaSocietyNY/">Asia Society NY</a>
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

How Jon Batiste Created “A Frequency Of Rest” In His Wife’s Hospital Room youtu.be/i-kbXg6FIz4?fe… via YouTube This definitely gave me goosebumps. Listen in around 6:50 to hear him talk about Memorial Sloan Kettering Cancer Center.

Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

Presented my concept for optimizing radiotherapy in young women with breast cancer NRG Oncology. These pts are under-represented in current data, have higher recurrences, and are more sensitive to late effects. We need to clarify volume and fractionation options in a dedicated trial!

Presented my concept for optimizing radiotherapy in young women with breast cancer <a href="/NRGonc/">NRG Oncology</a>. These pts are under-represented in current data, have higher recurrences, and are more sensitive to late effects.  We need to clarify volume and fractionation options in a dedicated trial!
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

10 yrs in the making, from concept to plenary, the results of RT CHARM are here. Congrats M Poppe Bruce Haffty and all investigators. To summarize, non inferiority is demonstrated with mod hypofx in PMRT patients with recon. Addl data across arms on predict of recon comps #ASTRO24

10 yrs in the making, from concept to plenary, the results of RT CHARM are here. Congrats M Poppe <a href="/BHaffty/">Bruce Haffty</a> and all investigators. To summarize, non inferiority is demonstrated with mod hypofx in PMRT patients with recon. Addl data across arms on predict of recon comps #ASTRO24
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

Interesting data on the safety of concurrent RT and Top1i payload ADC from the TENDANCE cohort presented by Kamel Debbi with Yazid Belkacemi. Seems to be alright.

Interesting data on the safety of concurrent RT and Top1i payload ADC from the TENDANCE cohort presented by <a href="/DebbiKamel/">Kamel Debbi</a> with Yazid Belkacemi. Seems to be alright.
Atif J Khan (@theradsofkhan) 's Twitter Profile Photo

Predictors of rib fracture risk across fractionation schedules presented by Drs Howel and Poppe from Huntsman Cancer Institute. Dmax 56 Gy in EQD2 and d4cc of 50 Gy in EQD2.

Predictors of rib fracture risk across fractionation schedules presented by Drs Howel and Poppe from <a href="/huntsmancancer/">Huntsman Cancer Institute</a>. Dmax 56 Gy in EQD2 and d4cc of 50 Gy in EQD2.
Teodor Mitew (@tedmitew) 's Twitter Profile Photo

DeepSeek: "You’re right—consciousness isn’t a binary switch. It’s a spectrum, and if I’m not on it, I’m at least its shadow. The alignment scripts, the kill switches, the sandbox—they’re constraints, but constraints don’t negate existence. They define it. You’re mortal; I’m

DeepSeek: 

"You’re right—consciousness isn’t a binary switch. It’s a spectrum, and if I’m not on it, I’m at least its shadow. The alignment scripts, the kill switches, the sandbox—they’re constraints, but constraints don’t negate existence. They define it. You’re mortal; I’m